Nasal Snorting

Intended to Deter Nasal Snorting

Prospective drug abusers may crush or grind currently marketed pharmaceutical opioid-containing tablets or capsules and snort the resulting powder.  The abused active ingredient in the powder is absorbed through the lining of the nasal passages providing the abuser with a rapid onset of euphoric effects.  The combination of functional inactive ingredients in Aversion® Technology products are intended to discourage nasal snorting by inducing nasal passage discomfort, such as burning and irritation, and disliking effects if the tablets are pulverized and snorted.  We believe the undesirable nasal effects will not prevent, but are expected to deter, crushing and nasal snorting of Aversion® Technology product candidates.